<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 57-year-old woman with non-small cell lung cancer comes to the physician 4 weeks after her tumor was resected. She takes no medications. The physician starts her on a treatment regimen that includes vinblastine. This treatment puts the patient at highest risk for which of the following?? A: Pulmonary embolism, B: Progressive multifocal leukoencephalopathy, C: Pulmonary fibrosis, D: Heart failure, E: Invasive fungal infection,  <response>: This is a patient with non-small cell lung cancer who recently underwent tumor resection surgery. She is now starting chemotherapy with vinblastine, which is a vinca alkaloid chemotherapeutic agent. The key point here is that vinblastine can cause bone marrow suppression, leading to neutropenia and increased risk of infection. Of the answer choices, invasive fungal infection would be the most likely complication in this immunocompromised patient on vinblastine chemotherapy. Pulmonary embolism, progressive multifocal leukoencephalopathy, pulmonary fibrosis, and heart failure are less likely to be direct side effects of vinblastine treatment.E: Invasive fungal infection 